Liver disease and HIV: Study reveals major gaps in liver fibrosis screening and offers a promising solution

Дата публикации: 06-08-2026 14:20:02

Thanks to antiretroviral therapy and improved control of viral hepatitis (HBV and HCV), people living with HIV generally live longer and healthier lives. However, liver disease remains common in this population and is one of the leading causes of death.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Precision screening and local care advance hepatitis C elimination	0	8.06	05-08-2026
2	<![CDATA[Long-acting lenacapavir plus cabotegravir kept all 46 patients with HIV virally suppressed in recent trial]]>	0	15.9	16-10-2026
3	<![CDATA[Long-Acting Cabotegravir/Rilpivirine Superior to Daily Oral ART for HIV ]]>	0	13.67	06-10-2026
4	<![CDATA[HHS Updates Guidelines for Antiretroviral Treatment of HIV]]>	0	7.94	18-10-2026
5	MASH Comorbidity Burden and Overall, Waiting List, and Post–Liver Transplant Mortality	0	8.64	05-08-2026
6	Exploring the impact of polypharmacy on treatment adherence among people living with HIV: A qualitative study at a primary healthcare facility in Mthatha, South Africa [version 1; peer review: awaiting peer review]	0	7.34	18-08-2026
7	The drug lenacapavir is a mighty weapon against HIV. Its rollout gets mixed reviews	0	8.59	13-08-2026
8	A surprising triple treatment completely clears hiv in newborn primates	0	7.93	13-08-2026
9	Long-term viral hepatitis control and changing patterns of liver cancer mortality in Japan	0	9.82	13-10-2026
10	Austin Public Health report examines HIV stigma in Central Texas	0	4.96	21-10-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 6.23. Источник: medicalxpress.com.